Contributing to seed-stage funding for start-up companies driven by the improvement of healthcare and medical technology, with a focus on biotechnology and healthcare IT.
Click on the links below for information about MJK’s investment strategy and interests:
For more information or to set up an appointment, contact Marc J. Kleinman: mjk@MJKlifescience.com